VOLT CE Mark Study

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 24, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Atrial ArrhythmiaAtrial FibrillationParoxysmal Atrial FibrillationPersistent Atrial Fibrillation
Interventions
DEVICE

Pulsed Field Ablation

Pulsed field ablation using the Volt PFA System

Trial Locations (16)

1090

RECRUITING

UZ Brussel, Brussels

1205

WITHDRAWN

Hôpital Cantonal Universitaire de Geneva, Geneva

3050

RECRUITING

Royal Melbourne Hospital - City Campus, Parkville

3168

RECRUITING

Monash Health, Clayton

4020

RECRUITING

A. ö. Krankenhaus der Elisabethinen Linz, Linz

4032

RECRUITING

The Prince Hospital, Chermside

5000

RECRUITING

Royal Adelaide Hospital, Adelaide

8000

RECRUITING

AZ Sint Jan, Bruges

10117

WITHDRAWN

Universitätsmedizin Berlin - Charité Campus Mitte (CCM), Berlin

15030

ACTIVE_NOT_RECRUITING

Nemocnice Na Homolce, Prague

23562

RECRUITING

Universitätsklinikum Schleswig-Holstein - Campus Lübeck, Lübeck

46026

RECRUITING

Hospital Universitari i Politècnic La Fe, Valencia

50937

WITHDRAWN

Medizinische Einrichtungen der Universität zu Köln, Cologne

60126

WITHDRAWN

Az. Osp.Universitaria Osp.Riuniti Umberto I-Lancisi-Salesi, Ancona

3584 CX

RECRUITING

UMC Utrecht, Utrecht

EC1A 7BE

WITHDRAWN

St. Bartholomew's Hospital, London

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT06106594 - VOLT CE Mark Study | Biotech Hunter | Biotech Hunter